TY - JOUR
T1 - Studying sex and gender in neurological disease
AU - Al-Hassany, Linda
AU - Verdonk, Petra
AU - VanDenBrink, Antoinette Maassen
PY - 2023/1
Y1 - 2023/1
N2 - Awareness is growing of the relevance of sex and gender for the incidence, prevalence, pathogenesis, diagnosis, manifestations, management, quality of life, and prognosis of various neurological diseases. For example, the occurrence of stroke varies substantially between men and women at different ages. Furthermore, there is mounting evidence that stroke signs and symptoms present differently in men and women, and that risk factors for stroke and other neurological diseases, such as Alzheimer's disease, also diverge. Differences in the biological genesis of disease, in the experience and reporting of symptoms, in health-care-seeking behaviour, and gendered interactions and biases in health care might lead to treatment differences between individuals. Gender can be viewed as a determinant not only of patients’ behaviour but also of neurologists’ behaviour, due to biases inherent in medical education.
AB - Awareness is growing of the relevance of sex and gender for the incidence, prevalence, pathogenesis, diagnosis, manifestations, management, quality of life, and prognosis of various neurological diseases. For example, the occurrence of stroke varies substantially between men and women at different ages. Furthermore, there is mounting evidence that stroke signs and symptoms present differently in men and women, and that risk factors for stroke and other neurological diseases, such as Alzheimer's disease, also diverge. Differences in the biological genesis of disease, in the experience and reporting of symptoms, in health-care-seeking behaviour, and gendered interactions and biases in health care might lead to treatment differences between individuals. Gender can be viewed as a determinant not only of patients’ behaviour but also of neurologists’ behaviour, due to biases inherent in medical education.
UR - https://www.scopus.com/pages/publications/85143977198
U2 - 10.1016/S1474-4422(22)00493-8
DO - 10.1016/S1474-4422(22)00493-8
M3 - Comment/Letter to the editor
C2 - 36517169
AN - SCOPUS:85143977198
SN - 1474-4422
VL - 22
SP - 32
EP - 33
JO - The Lancet Neurology
JF - The Lancet Neurology
IS - 1
ER -